GL1X · GenesisL1 explorer

MolNFT v1 · #229051 · protein

AlphaFold monomer V2.0 prediction for mediator of RNA polymerase II transcription subunit 26 (O95402)

O95402: “AlphaFold monomer V2.0 prediction for mediator of RNA polymerase II transcription subunit 26 (O95402)”. MolNFT v1 #229051 on GenesisL1: 3D structure, binding sites and pockets in GL1X.

Accession
O95402
Type
protein
Length
600 residues
Chains
1
Collection
MolNFT v1 / AlphaFold
Contract
0xBf7491af3407816DFa88a5EA4c82e8A2B1D721eD
Owner
0x5c4adF1416281C09AE8eE1cbb80fF7e44cE86F97
UniProt
O95402

Structure

1 distinct chain.

ChainMoleculeTypeResiduesSecondary structureUniProt
A—protein600—O95402

Compared structures

  • 6ZV3 · Tfiis N-terminal domain (tnd) from human MED26 · an experimental structure of the same protein · chain A against A, TM-score 0.14
  • 6ZV3 · TFIIS N-terminal domain (TND) from human MED26 · an experimental structure of the same protein · chain A against A, TM-score 0.14
  • 5ODD · Human MED26 N-terminal domain (1-92) · an experimental structure of the same protein · chain A against A, TM-score 0.13
  • 7ENC · TFIID-based PIC-Mediator holo-complex in fully-assembled state (hPIC-MED) · an experimental structure of the same protein · chain A against z, TM-score 0.12
  • 7ENA · TFIID-based PIC-Mediator holo-complex in pre-assembled state (pre-hPIC-MED) · an experimental structure of the same protein · chain A against z, TM-score 0.12
  • 7EMF · Human Mediator (deletion of MED1-IDR) in a Tail-extended conformation · an experimental structure of the same protein · chain A against Z, TM-score 0.12
  • 7EMF · Human mediator (deletion of MED1-idr) in a tail-extended conformation · an experimental structure of the same protein · chain A against Z, TM-score 0.12
  • 7ENJ · Human mediator (deletion of MED1-idr) in a tail-bent conformation (med-B) · an experimental structure of the same protein · chain A against Z, TM-score 0.12

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.